1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Nuron Biotech Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2, Multicenter, Open-label Study to Assess the Immunogenicity of an Investigational Hib Vaccine (NU300)in Toddlers NU300, ActHIB, Prevnar 13 - Infectious Disease | Phase 2 | Unknown | Nuron Biotech Inc. | 220 | 2013-03-01 | 2013-09-23 |
13-valent pneumococcal vaccine (1) · Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate (1)
United States (1)